Login / Signup

Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations.

Jesse ElliottBláthnaid McCoyTammy CliffordBeth K PotterBecky SkidmoreGeorge A WellsDoug Coyle
Published in: Systematic reviews (2019)
PROSPERO no.: CRD42018099591 .
Keyphrases
  • drug resistant
  • multidrug resistant
  • acinetobacter baumannii
  • randomized controlled trial
  • pseudomonas aeruginosa
  • young adults